207_Combined course Presentations

Median PFS time: 11.9 vs 3.9 months (p = 0.005)

Median time to new lesion: 11.9 vs 5.7 months (p = 0.049)

 Local consolidative therapy with or without maintenance therapy for patients with 3 or fewer metastases from NSCLC improved PFS compared with maintenance therapy alone.

 These findings suggest that aggressive local therapy should be further explored in phase III trials as a standard treatment option in this scenario

Gomez DR. et al. Lancet Oncol 2016